Eusol Biotech Co.,Ltd. (TPEX:6652)
6.56
+0.21 (3.31%)
Mar 10, 2026, 1:46 PM CST
Eusol Biotech Market Cap
Eusol Biotech has a market cap or net worth of 898.72 million as of March 9, 2026. Its market cap has decreased by -14.25% in one year.
Market Cap
898.72M
Enterprise Value
573.04M
Revenue
370.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
6.56
Market Cap Chart
Since August 29, 2018, Eusol Biotech's market cap has decreased from 5.42B to 898.72M, a decrease of -83.43%. That is a compound annual growth rate of -21.23%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neith | 899.73M |
| NatureWise Biotech & Medicals | 940.05M |
| TCI GENE | 949.86M |
| Taiwan Advance Bio-Pharmaceutical | 958.50M |
| BioLASCO Taiwan | 769.64M |
| SynCore Biotechnology Co.,Ltd | 715.61M |
| Level Biotechnology | 1.10B |
| Holy Stone Healthcare | 1.10B |